Brellium, a New York based mostly supplier of an AI-Powered medical compliance platform, raised $13.7m in Sequence A funding.
The spherical was co-led by First Spherical Capital and Left Lane Capital, with participation from Menlo Ventures, Digital Well being Enterprise Companions, and Obligatory Ventures, alongside a gaggle of angel buyers together with Andrew Adams (CEO of Headway), Steve Gutentag and Demitri Karagas (co-founders of Thirty Madison), Cory Levy (Z Fellows), and Fiat Ventures.
The corporate intends to make use of the funds to develop the staff, and speed up product roadmap.
Led by CEO Zach Rosen, Brellium supplies an AI platform for healthcare suppliers to streamline compliance throughout thousands and thousands of affected person visits. Scientific groups use it to make sure each affected person go to meets payor & medical high quality requirements – with out the guide workload. Brellium proactively audits each affected person go to, figuring out compliance dangers earlier than they turn into issues. Suppliers then obtain instantaneous notifications when charts want corrections, full with clear directions on repair them.
The corporate serves healthcare organizations like Develop Remedy, Rula, Headspace, Hopebridge, Lightfully Behavioral Well being, Talkiatry, and extra.
FinSMEs
21/04/2025
